NL-OMON39798
Completed
Not Applicable
Cardiac Arrhythmias in Refractory Epilepsy: identifying prevalence and LINKage between seizures and arrhythmias (CARELINK) - cardiac arrhythmias in epilepsy: the CARELINK-study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- asystole cardiac arrhythmia
- Sponsor
- Stichting Epilepsie Instellingen Nederland
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Drug\-resistant focal epilepsy: failure of adequate trials of two tolerated and appropriately chosen and used antiepileptic drug schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom
- •2\) \* 1 seizure/month as indicated by history taking
- •3\) If female, not pregnant
- •4\) Aged 18 to 60 years\*
- •5\) Able to undergo the study procedure as judged by the treating physician.;\*We have an instituted an age limit of 60 years in order to select a group of patients with as little comorbidity as possible, because this comorbidity could lead to asystole and other potentially dangerous arrhythmias irrespective of having epilepsy. In this pilot study it is important to maximize the power of a potential intervention (e.g. pacemaker implantation) after referral to a treating cardiologist based on the referral criteria we established: see also Section 3 STUDY DESIGN of the study protocol. In a larger follow\-up study this age limit of 60 years can then be abandoned. For similar reasons, Nei et al. used an age limit of 50 years in their previous Reveal XT study of people with epilepsy.
Exclusion Criteria
- •1\) Clinical suspicion of seizure\-induced asystole (e.g. seizures with sudden flaccid falls)
- •2\) Vagal nerve stimulator
- •3\) Reveal implantation (either present or in the past)
- •4\) Known clinical relevant structural cardiac disease
- •5\) Family history of sudden death or hereditary syndromes that increase the risk of cardiomyopathy (e.g. Marfan\*s disease)
- •6\) ECG findings suggestive of arrhythmias without proper cardiac evaluation to in\- or exclude this possibility. According to ESC guidelines on syncope the following ECG findings will be used: bifascicular block and other intraventricular conduction abnormalities, asymptomatic inappropriate sinus bradycardia (\<50 bpm), sinoatrial block or sinus pause \*3s in the absence of negative chronotropic medications, non\-sustained VT, pre\-exited QRS complexes, prolonged or short QT interval, Brugada pattern, pattern suggestive of arrythmogenic right ventricular cardiomyopathy.
- •7\) Pacemaker
- •8\) Use of beta blockers or other anti\-arrhythmic/anti\-arrhythmogenic medication (sotalol, amiodaron)
- •9\) Previous diagnosis of psychogenic non\-epileptic seizures
- •10\) Patients who live alone and are not able to recall their seizures
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Cardiac Arrhythmias in Epilepsy: the CARELINK-studyEpilepsyAsystoleCardiac ArrhythmiasNCT01946776Stichting Epilepsie Instellingen Nederland49
Not yet recruiting
Not Applicable
Electrocardiographic Changes Among Epileptic and Non Epileptic Seizures in Children at Sohag University HospitalSeizuresNCT06045676Sohag University160
Completed
Not Applicable
Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With EpilepsyEpilepsyNCT01214707Cyberonics, Inc.30
Recruiting
Not Applicable
The influence of seizures on myocardial function assessed with biomarkers and echocardiographyG40EpilepsyDRKS00031329Klinik für Anästhesie50
Terminated
Not Applicable
Long-term Cardiac Monitoring in EpilepsyFocal EpilepsyIntractable EpilepsyEpileptic EncephalopathyLennox Gastaut SyndromeSymptomatic EpilepsyGeneralized EpilepsyNCT03955432Northwell Health7